FDA Suspects Fraud Led To Heparin Contamination

Law360, New York (April 16, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration told a Senate hearing on Tuesday that Baxter International Inc.'s heparin, a blood thinner that has been linked to several deaths and allergic reactions, may have been contaminated purposefully in an attempt to lower the cost of the product.

The main ingredient in some samples of Baxter's heparin had been contaminated by a cheaper substance with similar qualities that was derived from animal cartilage, FDA Commissioner Dr. Andrew von Eschenbach said.

Though the agency is not completely sure that the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.